| Ms Karel M Koenig, APRN | |
|
374 Grand Ave, New Haven, CT 06513-3733 | |
| (203) 777-7411 | |
| Not Available |
| Full Name | Ms Karel M Koenig |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 374 Grand Ave, New Haven, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801903828 | NPI | - | NPPES |
| 002494 | Other | CT | LICENSE NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 002494 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Karel M Koenig, APRN 374 Grand Ave, New Haven, CT 06515-3733 Ph: (203) 777-7411 | Ms Karel M Koenig, APRN 374 Grand Ave, New Haven, CT 06513-3733 Ph: (203) 777-7411 |
News Archive
Hi-Tech Pharmacal Co., Inc., a specialty pharmaceuticals company, announced today that the US Food and Drug Administration granted final approval for the Company's Abbreviated New Drug Application for levofloxacin ophthalmic solution, 0.5% the generic for Vistakon's Quixin ophthalmic solution, which had sales of $2 million for the 12 months ended December 2010 according to IMS sales data.
IDEV Technologies, Inc. (IDEV), an emerging global innovator in peripheral devices, today announced that Private Healthcare Australia has granted the Company a reimbursement code for the SUPERA stent.
Expert scientists working with Environmental Health Trust, a nonprofit research and educational group, say that new studies showing that cell phone radiation excites the brain strengthen the need for a major research program on cell phones and health, revamping approaches to setting standards, and putting warnings on cell phones.
A push to fast-track an experimental treatment is gaining momentum, but questions persist about this serum's effectiveness, whether the drug should be brought to the places currently confronting outbreaks of the disease and who should have access to its limited supplies.
Marshall Edwards today announced that the U.S. Food and Drug Administration (FDA) has granted the investigational anti-cancer drug, phenoxodiol, Fast Track status for its intended use in patients with recurrent ovarian cancer.
› Verified 9 days ago
Joel Daniel Newman Bluman, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 374 Grand Ave, New Haven, CT 06513 Phone: 203-777-7411 Fax: 203-777-8506 | |
Obinna Anosike, Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Long Wharf Dr, New Haven, CT 06511 Phone: 203-781-4444 | |
Rebecca Arnold, PA-C Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 333 Cedar St, New Haven, CT 06510 Phone: 719-237-9972 | |
Dr. Dorothyann J Van Rhijn, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 55 Lock Street, New Haven, CT 06520 Phone: 203-432-0076 Fax: 203-432-7289 | |
Dr. Kyle Elligers, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 374 Grand Ave, New Haven, CT 06513 Phone: 203-777-7411 Fax: 203-777-8506 | |
Hadrian Holder, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 428 Columbus Avenue, New Haven, CT 06519 Phone: 203-503-3000 Fax: 203-503-3224 | |
Dr. Ashley L Demory, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-688-4242 |